Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.
acral melanoma
diagnosis
epidemiology
genomics
microenvironment
Journal
Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
18
02
2020
revised:
10
04
2020
accepted:
19
04
2020
pubmed:
25
4
2020
medline:
24
11
2021
entrez:
25
4
2020
Statut:
ppublish
Résumé
Acral lentiginous melanoma is a histological subtype of cutaneous melanoma that occurs in the glabrous skin of the palms, soles and the nail unit. Although in some countries, particularly in Latin America, Africa and Asia, it represents the most frequently diagnosed subtype of the disease, it only represents a small proportion of melanoma cases in European-descent populations, which is partially why it has not been studied to the same extent as other forms of melanoma. As a result, its unique genomic drivers remain comparatively poorly explored, as well as its causes, with current evidence supporting a UV-independent path to tumorigenesis. In this review, we discuss current knowledge of the aetiology and diagnostic criteria of acral lentiginous melanoma, as well as its epidemiological and histopathological characteristics. We also describe what is known about the genomic landscape of this disease and review the available biological models to explore potential therapeutic targets.
Identifiants
pubmed: 32330367
doi: 10.1111/pcmr.12885
pmc: PMC7818404
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-71Subventions
Organisme : Medical Research Council
ID : MR/S01473X/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204562/Z/16/Z
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
© 2020 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd.
Références
Br J Dermatol. 2015 Oct;173(4):1041-9
pubmed: 26211689
Br J Dermatol. 2018 Feb;178(2):443-451
pubmed: 28707317
Orthop Clin North Am. 2019 Jul;50(3):357-366
pubmed: 31084838
BMC Res Notes. 2015 Jan 16;8:4
pubmed: 25592837
Oncogene. 2003 May 19;22(20):3081-6
pubmed: 12789284
Pigment Cell Melanoma Res. 2014 Nov;27(6):1039-50
pubmed: 25065272
J Foot Ankle Res. 2010 Sep 28;3:22
pubmed: 20920168
Ann Diagn Pathol. 2017 Feb;26:64-69
pubmed: 27601330
Eur J Cancer. 2014 Apr;50(6):1176-83
pubmed: 24461199
Med Sci Monit. 2012 Oct;18(10):RA155-9
pubmed: 23018363
Dermatol Online J. 2009 Nov 15;15(11):1
pubmed: 19951637
Pigment Cell Melanoma Res. 2021 Jan;34(1):59-71
pubmed: 32330367
Oncotarget. 2017 Feb 28;8(9):14759-14769
pubmed: 28107203
J Expo Sci Environ Epidemiol. 2016 Nov;26(6):539-545
pubmed: 26464096
Cell Rep. 2016 Jun 28;16(1):263-277
pubmed: 27320919
Clin Dermatol. 2009 Nov-Dec;27(6):556-63
pubmed: 19880043
Histopathology. 2018 Jun;72(7):1189-1198
pubmed: 29415335
J Invest Dermatol. 2008 Aug;128(8):2024-30
pubmed: 18323782
Cancer Causes Control. 2009 Feb;20(1):115-9
pubmed: 18758972
Ann Surg Oncol. 2016 Dec;23(13):4189-4194
pubmed: 27401447
Sci Rep. 2017 Jul 17;7(1):5564
pubmed: 28717212
J Clin Aesthet Dermatol. 2009 Oct;2(10):34-6
pubmed: 20725572
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):732-736
pubmed: 27696528
J Invest Dermatol. 2014 Mar;134(3):754-763
pubmed: 23962810
J Invest Dermatol. 2018 Feb;138(2):384-393
pubmed: 28870692
Cell Rep. 2017 Nov 14;21(7):1953-1967
pubmed: 29141225
PLoS One. 2016 May 06;11(5):e0155215
pubmed: 27152848
Pigment Cell Melanoma Res. 2015 Jul;28(4):476-80
pubmed: 25847135
Br Med J. 1954 May 1;1(4869):1016-7
pubmed: 13149891
J Pathol. 2019 Apr;247(5):539-551
pubmed: 30511391
S Afr Med J. 1975 May 3;49(19):789-92
pubmed: 1138394
Pigment Cell Melanoma Res. 2011 Feb;24(1):35-50
pubmed: 21029393
J Clin Oncol. 2006 Sep 10;24(26):4340-6
pubmed: 16908931
Oncotarget. 2014 Oct 30;5(20):9609-18
pubmed: 25228592
Melanoma Res. 2004 Dec;14(6):537-41
pubmed: 15577327
JAMA Dermatol. 2013 Nov;149(11):1281-8
pubmed: 24067997
BMC Cancer. 2011 Feb 25;11:85
pubmed: 21349197
Cell Rep. 2017 Nov 14;21(7):1936-1952
pubmed: 29141224
Melanoma Res. 2018 Oct;28(5):458-464
pubmed: 30020197
J Cell Sci. 2010 Mar 15;123(Pt 6):853-60
pubmed: 20159965
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2043-54
pubmed: 20647408
Genome Res. 2017 Apr;27(4):524-532
pubmed: 28373299
APMIS. 2011 Jun;119(6):330-5
pubmed: 21569090
BMC Cancer. 2016 Aug 30;16:691
pubmed: 27576582
Cancer. 2016 Nov 15;122(21):3354-3362
pubmed: 27533633
Cell. 2020 Oct 1;183(1):197-210.e32
pubmed: 33007263
Clin Dermatol. 2013 Mar-Apr;31(2):166-78
pubmed: 23438380
Oncotarget. 2016 Jul 19;7(29):45916-45925
pubmed: 27322141
Expert Opin Drug Discov. 2008 Jan;3(1):1-10
pubmed: 23480136
Cancer Sci. 2007 Jul;98(7):958-63
pubmed: 17488338
Clin Transl Oncol. 2017 Dec;19(12):1478-1488
pubmed: 28577153
Int J Cancer. 2009 Feb 15;124(4):862-8
pubmed: 19035443
J Am Acad Dermatol. 2003 Feb;48(2):183-8
pubmed: 12582386
J Eur Acad Dermatol Venereol. 2014 May;28(5):597-603
pubmed: 23465057
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Exp Dermatol. 2013 Feb;22(2):148-50
pubmed: 23362874
J Natl Cancer Inst. 2019 Oct 1;111(10):1068-1077
pubmed: 30657954
Nat Med. 2002 Feb;8(2):157-65
pubmed: 11821900
Dermatol Clin. 2006 Jul;24(3):329-39
pubmed: 16798430
Clin Cancer Res. 2018 Oct 1;24(19):4771-4784
pubmed: 29563139
Exp Dermatol. 2017 Oct;26(10):883-888
pubmed: 28191690
Cancer. 2017 Jun 1;123(S11):2089-2103
pubmed: 28543694
Int J Clin Oncol. 2008 Feb;13(1):33-41
pubmed: 18307017
Ann Dermatol. 2014 Aug;26(4):485-90
pubmed: 25143678
Nat Rev Cancer. 2017 Jul;17(7):393-394
pubmed: 28450704
S Afr Med J. 2016 Dec 21;107(1):83-88
pubmed: 28112098
J Am Acad Dermatol. 2005 Jan;52(1):109-21
pubmed: 15627088
Clin Transl Oncol. 2019 Sep;21(9):1127-1134
pubmed: 30778854
Melanoma Manag. 2017 May;4(2):113-123
pubmed: 30190914
Int J Cancer. 2016 May 15;138(10):2322-33
pubmed: 26455580
J Surg Oncol. 2009 Feb 1;99(2):114-8
pubmed: 19034932
Int J Dermatol. 2017 Jan;56(1):40-48
pubmed: 27785785
S Afr Med J. 2018 Aug 28;108(9):777-781
pubmed: 30182904
Cancer Discov. 2016 Mar;6(3):286-99
pubmed: 26715644
Ann Dermatol. 2014 Aug;26(4):469-73
pubmed: 25143675
Ann Acad Med Singap. 2012 Jan;41(1):17-20
pubmed: 22499476
Mediators Inflamm. 2014;2014:105950
pubmed: 24904196
N Engl J Med. 2017 Jul 27;377(4):395-396
pubmed: 28745985
Clin Cancer Res. 2017 Nov 15;23(22):6946-6957
pubmed: 28830923
J Am Acad Dermatol. 2019 Sep;81(3):805-812
pubmed: 30731177
Cancer Res. 2000 Apr 1;60(7):1968-73
pubmed: 10766187
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
J Dtsch Dermatol Ges. 2008 May;6(5):386-8
pubmed: 18042248
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Int J Dermatol. 2005 Oct;44 Suppl 1:44-5
pubmed: 16187961
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
N Engl J Med. 2016 Jun 16;374(24):2404-6
pubmed: 27305207
Pigment Cell Melanoma Res. 2012 Jul;25(4):488-92
pubmed: 22578220
Mol Cancer Ther. 2009 Aug;8(8):2079-85
pubmed: 19671763
J Am Coll Surg. 1995 Jan;180(1):65-71
pubmed: 8000657
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Cancer Causes Control. 1999 Feb;10(1):21-5
pubmed: 10334638
J Clin Oncol. 2013 Sep 10;31(26):3182-90
pubmed: 23775962
Melanoma Res. 2017 Apr;27(2):145-151
pubmed: 27926588
Melanoma Res. 1997 Aug;7 Suppl 2:S35-42
pubmed: 9578415
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Arch Dermatol. 2009 Apr;145(4):427-34
pubmed: 19380664
J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1555-60
pubmed: 27538731
Arch Surg. 1995 Jan;130(1):88-92
pubmed: 7802583
Br J Dermatol. 2000 Aug;143(2):275-80
pubmed: 10951133
Rev Med Chil. 1994 Aug;122(8):900-6
pubmed: 7761720
Biol Res. 2014;47:34
pubmed: 25204018
Clin Cancer Res. 2019 Nov 1;25(21):6511-6523
pubmed: 31375512